Mitochondrial function and content in pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers

Endocrine-Related Cancer

Volumn 19, Issue 3, 2012, Pages 261-269

  Rapizzi, E ^a   Ercolino, T ^b   Canu, L ^a   Giache V ^a   Francalanci, M ^a   Pratesi, C ^a   Valeri, A ^b   Mannelli, M ^a,c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c ISTITUTO TOSCANO TUMORI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CITRATE SYNTHASE; CYTOCHROME C OXIDASE; MAX PROTEIN; MITOCHONDRIAL PROTEIN; PROTEIN TMEM127; SUCCINATE DEHYDROGENASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DELETION; GENE MUTATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE; GERM LINE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MITOCHONDRION; PARAGANGLIOMA; PATHOGENESIS; PHEOCHROMOCYTOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC MUTATION;

ADRENAL GLAND NEOPLASMS; CITRATE (SI)-SYNTHASE; ELECTRON TRANSPORT COMPLEX IV; GERM-LINE MUTATION; HUMANS; MITOCHONDRIA; PHEOCHROMOCYTOMA; RNA, MESSENGER; SUCCINATE DEHYDROGENASE; VOLTAGE-DEPENDENT ANION CHANNELS;

EID: 84862654410     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-11-0263     Document Type: Article

References (33)

1. Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, Chamontin B, Delemer B, Giraud S, Murat A et al. 2005 Genetic testing in pheochromocytoma or functional paraganglioma. Journal of Clinical Oncology 23 8812-8818. (doi:10.1200/JCO.2005.03.1484)
2. Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Sköldberg F, Husebye ES, Eng C & Maher ER 2001 Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. American Journal of Human Genetics 69 49-54. Erratum in: Am J Hum Genet 2002, 70 565. (doi:10.1086/321282) (Pubitemid 32614017)
3. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PE, Rubinstein WS, Myers EN et al. 2000 Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287 848-851. (doi:10.1126/ science.287.5454.848)
4. Burnichon N, Brière JJ, Libé R, Vescovo L, Rivière J, Tissier F, Jouanno E, Jeunemaitre X, Bénit P, Tzagoloff A et al. 2010 SDHA is a tumor suppressor gene causing paraganglioma. Human Molecular Genetics 19 3011-3020. (doi:10.1093/hmg/ddq206)
5. Cascon A, Ruiz-Llorente S, Cebrian A, Telleria D, Rivero JC, Diez JJ, Lopez-Ibarra PJ, Jaunsolo MA, Benitez J & Robledo M 2002 Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma. European Journal of Human Genetics 10 457-461. (doi:10.1038/sj.ejhg.5200829)
6. Comino-Méndez I, Gracia-Aznárez FJ, Schiavi F, Landa I, Leandro-García LJ, Letón R, Honrado E, Ramos-Medina R, Caronia D, Pita G et al. 2011 Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nature Genetics 43 663-667. (doi:10. 1038/ng.861)
7. Dahia PL, Ross KN, Wright ME, Hayashida CY, Santagata S, Barontini M, Kung AL, Sanso G, Powers JF, Tischler AS et al. 2005 A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genetics 1 72-80. (doi:10.1371/journal.pgen.0010008)
8. Douwes Dekker PB, Hogendoorn PC, Kuipers-Dijkshoorn N, Prins FA, van Duinen SG, Taschner PE, van der Mey AG & Cornelisse CJ 2003 SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormalmitochondrialmorphology. Journal of Pathology 201 480-486. (doi:10.1002/path.1461)
9. Eng C 1996 Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease. New England Journal of Medicine 335 943-951. (doi:10.1056/ NEJM199609263351307)
10. Eng C, Smith DP, Mulligan LM, Nagal MA, Healey CS, Ponder MA, Gardner E, Scheumann GFW, Jackson CE, Tunnacliffe A et al. 1994 Pointmutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Human Molecular Genetics 3 237-241. Erratum in: Hum Mol Genet 1994, 3 686. (doi:10.1093/hmg/3.2.237) (Pubitemid 24060936)
11. Favier J, Brière JJ, Burnichon N, Rivière J, Vescovo L, Benit P, Giscos-Douriez I, De Reyniès A, Bertherat J, Badoual C et al. 2009 The Warburg effect is genetically determined in inherited pheochromocytomas. PLoS ONE 4 e7094. (doi:10.1371/journal.pone.0007094)
12. Ghezzi D, Goffrini P, Uziel G, Horvath R, Klopstock T, Lochmüller H, D'Adamo P, Gasparini P, Strom TM, Prokisch H et al. 2009 SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy. Nature Genetics 41 654-656. (doi:10.1038/ng.378)
13. Gimenez-Roqueplo AP, Favier J, Rustin P, Mourad JJ, Plouin PF, Corvol P, Rötig A & Jeunemaitre X 2001 The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. American Journal of Human Genetics 69 1186-1197. (doi:10.1086/324413)
14. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Kerlan V, Plouin PF, Rötig A & Jeunemaitre X 2002 Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. Journal of Clinical Endocrinology and Metabolism 87 4771-4774. (doi:10.1210/jc.2002-020525)
15. Hao HX, Khalimonchuk O, Schraders M, Dephoure N, Bayley JP, Kunst H, Devilee P, Cremers CW, Schiffman JD, Bentz BG et al. 2009 SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325 1139-1142. (doi:10.1126/science.1175689)
16. Kirby DM, Thorburn DR, Turnbull DM & Taylor RW 2007 Biochemical assay of the respiratory chain complex activity. Methods in Cell Biology 80 93-119. (doi:10. 1016/S0091-679X(06)80004-X)
17. Latif F, Tory K, Gnarra J, Yao M, Duh F-M, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L et al. 1993 Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260 1317-1320. (doi:10.1126/ science.8493574)
18. Linnoila RI, Keiser HR, Steinberg SM & Lack EE 1990 Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Human Pathology 21 1168-1180. (doi:10.1016/0046- 8177(90)90155-X)
19. Livak KJ & Schmittgen TD 2001 Analysis of relative gene expression data using real time quantitative PCR and the 2(KDelta Delta C(T)) method. Methods 25 402-408. (doi:10.1006/meth.2001.1262)
20. Lombardi A, Cantini G, Piscitelli E, Gelmini S, Francalanci M, Mello T, Ceni E, Varano G, Forti G, Rotondi M et al. 2008 A new mechanism involving ERK contributes to rosiglitazone inhibition of tumornecrosis factor-alpha and interferon-gamma inflammatory effects in human. Arteriosclerosis, Thrombosis, and Vascular Biology 28 718-724. (doi:10.1161/ATVBAHA.107.160713)
21. Mannelli M, Ercolino T, Giachè V, Simi L, Cirami C&Parenti G 2007 Genetic screening for pheochromocytoma: should SDHC gene analysis be included? Journal of Medical Genetics 44 586-587. (doi:10.1136/jmg.2007.051045)
22. Neumann HP, Berger DP, Sigmund G, Blum U, Schmidt D, Parmer RJ, Volk B & Kirste G 1993 Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. New England Journal of Medicine 329 1531-1538. Erratum in: N Engl J Med 1994, 331 1535. (doi:10.1056/NEJM199311183292103) (Pubitemid 23332438)
23. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K et al. 2002 Germ line mutations in non syndromic pheochromocytoma. New England Journal of Medicine 346 1459-1466. (doi:10.1056/NEJMoa020152)
24. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA et al. 2004 Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. Journal of the American Medical Association 292 943-951. (doi:10.1001/jama.292.8.943)
25. Niemann S & Müller U 2000 Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nature Genetics 26 268-270. (doi:10.1038/81551)
26. Pham TH, Moir C, Thompson GB, Zarroug AE, Hamner CE, Farley D, van Heerden J, Lteif AN & Young WF Jr 2006 Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center. Pediatrics 118 1109-1117. (doi:10.1542/peds.2005-2299)
27. Qin Y, Yao L, King EE, Buddavarapu K, Lenci RE, Chocron ES, Lechleiter JD, Sass M, Aronin N, Schiavi F et al. 2010 Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nature Genetics 42 229-233. (doi:10.1038/ng.533)
28. Rapizzi E, Taddei ML, Fiaschi T, Donati C, Bruni P & Chiarugi P 2009 Sphingosine 1-phosphate increases glucose uptake through trans-activation of insulin receptor. Cellular and Molecular Life Sciences 66 3207-3218. (doi:10.1007/s00018-009-0106-3)
29. Schiavi F, Boedeker CC, Bausch B, Peçzkowska M, Gomez CF, Strassburg T, Pawlu C, Buchta M, Salzmann M, Hoffmann MM et al. 2005 Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. Journal of the American Medical Association 294 2057-2063. (doi:10.1001/jama.294.16.2057)
30. Simi L, Sestini R, Ferruzzi P, Gaglianò MS, Gensini F, Mascalchi M, Guerrini L, Pratesi C, Pinzani P, Nesi G et al. 2005 Phenotype variability of neural crest derived tumours in six Italian families segregating the same founder SDHD mutation Q109X. Journal of Medical Genetics 42 e52. (doi:10.1136/jmg.2004.030353)
31. Timmers HJ, Kozupa A, Eisenhofer G, Raygada M, Adams KT, Solis D, Lenders JW & Pacak K 2007 Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with SDHB-associated pheochromocytomas and paragangliomas. Journal of Clinical Endocrinology and Metabolism 92 326-332. (doi:10.1210/jc.2006-2315)
32. Walther MM, Reiter R, Keiser HR, Choyke PL, Venzon D, Hurley K, Gnarra JR, Reynolds JC, Glenn GM, Zbar B et al. 1999 Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. Journal of Urology 162 659-664. (doi:10.1097/ 00005392-199909010-00004)
33. White R & O'Connell P 1991 Identification and characterization of the gene for neurofibromatosis type 1. Current Opinion in Genetics & Development 1 15-19. (doi:10. 1016/0959-437X(91)80034-J)